Creating Inclusive KAP Training Practices with TRIPP Founder Jennifer Montjoy
Discussing the lack of diversity in the psychedelics space with Jennifer Montjoy.
Similar Posts
MindMed Insiders DUMP Shares…AGAIN. Should we be Worried?
Here are my thoughts on MindMed’s CEO Jr Rahn and Board member Bruce Linton’s recent shares sell-off.
Resources:
How much JR sold from MMED/ MNMD:
https://thedeepdive.ca/mind-medicine-sees-ceo-sell-24-7-million-in-company-stock/
Stated reason for the sale:
https://twitter.com/PsilocybinAlpha/status/1397951345240461313/photo/1
How much MindMed stock JR Sold in the past:
https://seekingalpha.com/article/4411079-mind-medicine-great-potential-questionable-business-model
Insider selling SEC rules:
Sec rule regulation:
https://www.investopedia.com/terms/r/rule-10b5-1.asp
Canada and the SEC:
https://sec.report/CIK/0000230098
MindMed’s compensation packages as published on April 27, 2021
https://www.sedar.com/GetFile.do?lang=EN&docClass=10&issuerNo=00030583&issuerType=03&projectNo=03209908&docId=4942116
Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
Follow us on social media! 🙌
Instagram: @psychedelicinvestor
Email: thepsychedelicinvestor@gmail.com
Facebook: @thepsychedelicinvestor
Music: www.bensound.com
https://benzinga.grsm.io/jameshallifax1834
https://benzinga.grsm.io/thepsychedelicinvestor
bruce linton image: https://www.rollingstone.com/culture/culture-news/bruce-linton-canopy-growth-ceo-fired-marijuana-855361/
DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.
All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change.
#MindMed #MindMedNews #MindMedstock
How Psychedelics Helped Me Embrace Polyamory
How psychedelics shaped my understanding and acceptance of polyamorous relationships.
How Does Sound Therapy Enhance the Psychedelic Experience?
Tools for psychedelic sound therapy are becoming more popular. Here’s how you can use sound to enhance your psychedelic experience.
Medical Applications of Ketamine & Common Misconceptions with Christi Myers, Flow Integrative
In this episode, Christi provides insight into how ketamine impacts people’s physical and mental health. She goes into the comparison of ketamine’s effects compared to other psychedelics and how Flow Integrative’s patient care is unique.
Psychedelic Business Roundup- Key Psychedelic Industry Leader Joins The NASDAQ
May 12, 2021- This week’s Psychedelic Business News Round Up’s…
![Speculating on The Future of MindMed [Big News for MMED/MMEDF STOCK]](https://psychedelicspotlight.com/wp-content/uploads/2022/06/maxresdefault-36-600x338.jpeg)
Speculating on The Future of MindMed [Big News for MMED/MMEDF STOCK]
Hello back Psychedelic Investors! In this video we are going to be entering the Speculation Zone to discuss the implications of several of MindMed’s most recent moves. Aka, we shall be Speculating on The Future of MindMed [Big News for MMED/MMEDF STOCK].
Timestamps:
0:00 – Intro
2:52 – Speculating on LSD Trials
7:44 – MindMed’s Partnership Meaning
13:45 – Nasdaq Uplisting
This is actually the second video being released today. Earlier we posted a video detailing the three most recent press releases distributed by MindMed, where we explained what each move meant. If you haven’t seen that episode yet and want to get a detailed explanation of each Press Release before watching this video speculating on that information, you should probably do that first!
Well actually, MindMed has since released another press release since the first video was filmed, on the commencement of their LSD Neutraliser phase 1 clinical trial.
In our Video on MindMed’s Latest News, we discussed:
1. How MindMed has started a phase 1 clinical trial studying the effects of mixing LSD and MDMA;
2. We examined MindMed’s changes in Leadership, where JR Rahn became the sole CEO, and a gentleman by the name of Dr. Glick left the board;
3. We also talked about MindMed’s new partnership with a company called MindShift Compounds AG, which is developing novel compounds owned exclusively by MMED.
In this video, we discuss/SPECULATE on all of MindMed’s latest changes and how some of them could potentially influence the MMED/MMEDF stock’s uplisting on NASDAQ.
I hope you guys found some value in this and I’ll keep you posted for more changes!
Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
Follow us on social media! 🙌
Instagram: @psychedelicinvestor
Facebook: @thepsychedelicinvestor
Music: www.bensound.com
Video by Pressmaster from Pexels
DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.
#MindMed #MMEDF #MindmedStock